Medical Condition News

RSS

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

COVID-19 vaccination rates among minority populations

A new study discusses offers insights into how minority groups can be effectively persuaded to take the currently available COVID-19 vaccines.

10 Oct 2021

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

The researchers assessed the effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection and COVID-19-related hospitalization and deaths.

10 Oct 2021

Lipids, COVID-19, and host immunity

A new study from a team of researchers at the University of Pennsylvania examines the role played by lipids in this disease.

10 Oct 2021

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Hospital admissions and deaths due to COVID-19 were drastically reduced at two weeks or more from the first dose of either the Pfizer or AstraZeneca vaccine.

10 Oct 2021

Study reveals rising rates of depressive and anxiety disorders due to COVID-19 pandemic

Cases of major depressive disorder and anxiety disorders have increased by more than 25 per cent worldwide, according to a world-first study of the impact of COVID-19 on mental health.

8 Oct 2021

New digital program to improve physical and mental wellbeing of young cancer survivors

A digital program enhancing physical and mental wellbeing for young people adjusting to life after cancer, will be developed by The University of Queensland in partnership with cancer support organisation Canteen.

8 Oct 2021

TTUHSC investigator evaluates the potential of neurolysin as a therapeutic target for stroke

Ischemic stroke, the second leading cause of death worldwide, occurs when a vessel to the brain is blocked, reducing blood flow to the brain and depriving it of critical supplies of oxygen and nutrients.

8 Oct 2021

Tracking ADHD symptoms, behavior in people with intellectual disability using a smartphone app

A new study by the UC Davis MIND Institute's David Hessl will test whether a smartphone-based app may help improve the accuracy of data in some clinical trials involving individuals with intellectual disability.

8 Oct 2021

Genetics can influence a person's response to Alzheimer's disease pathology, research suggests

A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimer's disease pathology.

8 Oct 2021

Wyss Center to lead a collaborative project aimed at improving brain cancer treatment

The Wyss Center announced today that it will lead a collaborative project, as part of Wellcome Leap's Delta Tissue Program, to improve understanding of the brain cancer glioblastoma (GBM) and help develop more effective therapies.

8 Oct 2021

Experts address questions on psoriasis patients’ true needs and wellbeing

Almirall S.A., a global biopharmaceutical company focused on skin health, has hosted a scientific session during the 30th EADV Congress which addressed the need and importance to focus on patient wellbeing in real-life clinical practice.

8 Oct 2021

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.

8 Oct 2021

Chilblain-like lesions and COVID-19

The ongoing COVID-19 pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been responsible for various cutaneous manifestations. Among them, chilblain-like lesions (CLL) have been found to occur more frequently.

7 Oct 2021

Israeli Pfizer COVID vaccine/myocarditis study, 136 cases out of 5 million

A new study, published in the New England Journal of Medicine, aimed to present clinical, epidemiological, and follow-up findings of myocarditis cases diagnosed in temporal proximity to COVID-19 vaccination and explore the possibility of a causal relationship between the two.

7 Oct 2021

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

A peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint inhibitors in preclinical cancer models, according to results presented at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021.

7 Oct 2021

Study uncovers new drug target for myelodysplastic syndrome

Mount Sinai and UC San Diego researchers have shown for the first time how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and solid tumors, according to a study published in Cancer Discovery in October.

7 Oct 2021

High fat diet exacerbates Alzheimer's disease in mouse model

Research has shown that individuals who have diabetes are more prone to develop dementia. Although people are widely aware of diabetes, owing to its common occurrence, they are less aware of prediabetes. Similar to diabetes, prediabetes is also associated with impaired glucose tolerance. However, unlike diabetes, patients with prediabetes show a slight increase in insulin and fasting blood glucose rather than hyperglycemia.

7 Oct 2021

Additional health care support needed to improve medication adherence among people with hypertension

People with hypertension, or high blood pressure, play a key role in whether they use medication appropriately to manage their blood pressure.

7 Oct 2021

New conceptual framework for protecting urban mental health

People who live in cities face many challenges that threaten their mental health. In countries in which relatively higher numbers of people live in cities, depression, anxiety and addiction are generally more common.

7 Oct 2021

Medical Condition News

The neurological effects of COVID-19

COVID-19 vaccination rates among minority populations

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Lipids, COVID-19, and host immunity

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Study reveals rising rates of depressive and anxiety disorders due to COVID-19 pandemic

New digital program to improve physical and mental wellbeing of young cancer survivors

TTUHSC investigator evaluates the potential of neurolysin as a therapeutic target for stroke

Tracking ADHD symptoms, behavior in people with intellectual disability using a smartphone app

Genetics can influence a person's response to Alzheimer's disease pathology, research suggests

Wyss Center to lead a collaborative project aimed at improving brain cancer treatment

Experts address questions on psoriasis patients’ true needs and wellbeing

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

Chilblain-like lesions and COVID-19

Israeli Pfizer COVID vaccine/myocarditis study, 136 cases out of 5 million

Novel peptide-drug conjugate enhances the efficacy of immunotherapy in preclinical cancer models

Study uncovers new drug target for myelodysplastic syndrome

High fat diet exacerbates Alzheimer's disease in mouse model

Additional health care support needed to improve medication adherence among people with hypertension

New conceptual framework for protecting urban mental health

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News